Introduction: The knowledge of high sensitivity cardiac troponin I (hsTnI) distribution in a reference population is mandatory for its introduction in clinical practice. The aim of this study was to define the Upper Reference Limit (URL) of hsTnI measured by Single Molecule Counting technology (SMC) in an accurately selected reference population. Materials and methods: In the study 1140 blood donors were included and selected on the basis of medical history and biomarkers. High sensitivity cardiac troponin I was measured by SMC technology (Clarity, Singulex, Alamed, USA). The 99th percentile was calculated by the non-parametric method according to the Clinical and Laboratory Standard Institute-CLSI C28-A3. Results: The median age was 41 yea...
AbstractBackgroundHere we describe the determination of upper reference limits (URL) for galectin-3,...
The 99th percentile upper reference limits (URL) of high-sensitivity cardiac troponin (hs-cTn) in he...
The International Federation of Clinical Chemistry Committee on Clinical Application of Cardiac Bio-...
Introduction: The knowledge of high sensitivity cardiac troponin I (hsTnI) distribution in a referen...
Introduction: The knowledge of high sensitivity cardiac troponin I (hsTnI) distribution in a referen...
Introduction of high-sensitivity cardiac troponin I (hscTn I) assays for routine clinical use in Mal...
Background: The aim of this study is to determine the 99th upper-reference limit (URL) for cardiac t...
Background: The aim of this study is to determine the 99th upper-reference limit (URL) for cardiac t...
Establishment and evaluation of cardiac troponin I reference values measured in a group of Italian h...
OBJECTIVE:We sought to determine the effect of patient selection on the 99th reference percentile of...
Objective To determine the distribution, and specifically the true 99th centile, of high sensitivity...
ObjectivesThe study sought to determine the 99th percentile upper reference limit for the high-sensi...
The detection of an increase and/or decrease of cardiac troponin (cTnI) values, with at least one va...
According to recent international guidelines, including the 2012 Third Universal Definiton of Myocar...
Contains fulltext : 190538.pdf (publisher's version ) (Open Access)BACKGROUND: The...
AbstractBackgroundHere we describe the determination of upper reference limits (URL) for galectin-3,...
The 99th percentile upper reference limits (URL) of high-sensitivity cardiac troponin (hs-cTn) in he...
The International Federation of Clinical Chemistry Committee on Clinical Application of Cardiac Bio-...
Introduction: The knowledge of high sensitivity cardiac troponin I (hsTnI) distribution in a referen...
Introduction: The knowledge of high sensitivity cardiac troponin I (hsTnI) distribution in a referen...
Introduction of high-sensitivity cardiac troponin I (hscTn I) assays for routine clinical use in Mal...
Background: The aim of this study is to determine the 99th upper-reference limit (URL) for cardiac t...
Background: The aim of this study is to determine the 99th upper-reference limit (URL) for cardiac t...
Establishment and evaluation of cardiac troponin I reference values measured in a group of Italian h...
OBJECTIVE:We sought to determine the effect of patient selection on the 99th reference percentile of...
Objective To determine the distribution, and specifically the true 99th centile, of high sensitivity...
ObjectivesThe study sought to determine the 99th percentile upper reference limit for the high-sensi...
The detection of an increase and/or decrease of cardiac troponin (cTnI) values, with at least one va...
According to recent international guidelines, including the 2012 Third Universal Definiton of Myocar...
Contains fulltext : 190538.pdf (publisher's version ) (Open Access)BACKGROUND: The...
AbstractBackgroundHere we describe the determination of upper reference limits (URL) for galectin-3,...
The 99th percentile upper reference limits (URL) of high-sensitivity cardiac troponin (hs-cTn) in he...
The International Federation of Clinical Chemistry Committee on Clinical Application of Cardiac Bio-...